Clinical trials carried out in the United States, South America and other countries in Europe on the efficacy of human papillomavirus (HPV) quadrivalent vaccine in the protection against genital warts has been published. In addition, studies are being carried out to determine the incidence of genital warts and the potential impact of HPV vaccination in the United Kingdom.